LEADER 02133nam  2200601 a 450 
001 9910824238303321
005 20240410170148.0
010   $a1-61761-457-2
035   $a(CKB)2550000001042096
035   $a(EBL)3019248
035   $a(SSID)ssj0000854109
035   $a(PQKBManifestationID)12308034
035   $a(PQKBTitleCode)TC0000854109
035   $a(PQKBWorkID)10902974
035   $a(PQKB)10486015
035   $a(MiAaPQ)EBC3019248
035   $a(Au-PeEL)EBL3019248
035   $a(CaPaEBR)ebr10670813
035   $a(OCoLC)830627853
035   $a(EXLCZ)992550000001042096
100   $a20091020d2010      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aAMPK-S6K1 signaling pathway as a target for treating hepatic insulin resistance$b[electronic resource] /$fSang Geon Kim, Il Je Cho and Hee Yeon Kay
205   $a1st ed.
210   $aNew York $cNova Science Publishers$dc2010
215   $a1 online resource (69 p.)
225 1 $aHepatology research and clinical developments series
300   $aDescription based upon print version of record.
311   $a1-60876-693-4 
320   $aIncludes bibliographical references (p. [33]-49) and index.
327   $aIntroduction: Insulin signaling in hepatocytes -- Clinical and preclinical drugs for the treatment of hepatic insulin resistance.
410  0$aHepatology research and clinical developments series.
606   $aInsulin resistance$xMolecular aspecsts
606   $aLiver$xDiseases$xMolecular aspecsts
606   $aProtein kinases
615  0$aInsulin resistance$xMolecular aspecsts.
615  0$aLiver$xDiseases$xMolecular aspecsts.
615  0$aProtein kinases.
676   $a616.3/6207
700   $aKim$b Sang Geon$01654283
701   $aCho$b Il Je$01654284
701   $aKay$b Hee Yeon$01654285
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910824238303321
996   $aAMPK-S6K1 signaling pathway as a target for treating hepatic insulin resistance$94006014
997   $aUNINA